Literature DB >> 15608009

Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases.

K Ray Chaudhuri1, M Buxton-Thomas, V Dhawan, R Peng, C Meilak, D J Brooks.   

Abstract

BACKGROUND: Patients presenting with asymmetrical postural tremor with or without mild rest tremor may be diagnosed as having essential tremor (ET), although there is considerable diagnostic uncertainty as to the long term outcome of these patients.
OBJECTIVE: In this study, retrospective observations were made on 13 patients presenting originally with asymmetrical postural tremor, initially thought to have ET based on tremor characteristics, alcohol responsiveness, and family history but who subsequently met the criteria of Parkinson's disease (PD).
METHODS: The patients were observed and followed up clinically with ancillary imaging using dopamine transporter SPECT scan or levodopa challenge tests in some cases. The diagnosis at original presentation with postural tremor was made with retrospective case note review.
RESULTS: After a variable and long latent period all patients developed additional signs suggesting a clinical diagnosis of PD although picking up an initial label of ET.
CONCLUSIONS: We suggest exercising caution regarding a diagnosis of ET in patients presenting with late onset asymmetrical postural tremor even if there is no rest tremor. Alcohol sensitivity of tremor, family history of tremor, or responsiveness to beta blockers may not be helpful in diagnosing ET in these cases and some may develop PD in the long term.

Entities:  

Mesh:

Year:  2005        PMID: 15608009      PMCID: PMC1739293          DOI: 10.1136/jnnp.2004.046292

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

Review 1.  Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence?

Authors:  Hiral LaRoia; Elan D Louis
Journal:  Neuroepidemiology       Date:  2011-07-13       Impact factor: 3.282

Review 2.  The emerging neuropathology of essential tremor.

Authors:  Elan D Louis; Jean Paul G Vonsattel
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

3.  Reduced Purkinje cell number in essential tremor: a postmortem study.

Authors:  Jordan E Axelrad; Elan D Louis; Lawrence S Honig; Ingrid Flores; G Webster Ross; Rajesh Pahwa; Kelly E Lyons; Phyllis L Faust; Jean Paul G Vonsattel
Journal:  Arch Neurol       Date:  2008-01

Review 4.  It is time to remove the 'benign' from the essential tremor label.

Authors:  Elan D Louis; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-04-12       Impact factor: 4.891

5.  Population-based prospective study of cigarette smoking and risk of incident essential tremor.

Authors:  Elan D Louis; Julián Benito-León; Félix Bermejo-Pareja
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

Review 6.  Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.

Authors:  Elan D Louis; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

7.  Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients.

Authors:  Mia T Minen; Elan D Louis
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

8.  The primary type of tremor in essential tremor is kinetic rather than postural: cross-sectional observation of tremor phenomenology in 369 cases.

Authors:  E D Louis
Journal:  Eur J Neurol       Date:  2012-08-27       Impact factor: 6.089

Review 9.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

Review 10.  Is there a one-way street from essential tremor to Parkinson's disease? Possible biological ramifications.

Authors:  E D Louis; R Ottman
Journal:  Eur J Neurol       Date:  2013-09-12       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.